Pediatric pharmacogenetics in the community: a future where all children benefit from personalized therapeutics

Pediatr Res. 2025 Dec;98(6):1991-1992. doi: 10.1038/s41390-025-04213-8. Epub 2025 Jun 20.

Tamorah Lewis^{1

2}, Chris D Stone^{3

4}, Laura Ramsey^{4

5}

¹ Department of Paediatrics, University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada. Tamorah.Lewis@sickkids.ca.
² Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children, Toronto, ON, Canada. Tamorah.Lewis@sickkids.ca.
³ Division of General Academic Pediatrics, Children's Mercy Kansas City, Kansas City, MO, USA.
⁴ Department of Pediatrics, University of Missouri-Kansas City, Kansas City, MO, USA.
⁵ Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO, USA.

No abstract available